Mexiletine Shortens the QT Interval in Patients With Potassium Channel–Mediated Type 2 Long QT Syndrome-Reference-Cited by-同舟云学术

Mexiletine Shortens the QT Interval in Patients With Potassium Channel–Mediated Type 2 Long QT Syndrome

Published:2019-05 Issue:5 Volume:12 Page:
ISSN:1941-3149
Container-title:Circulation: Arrhythmia and Electrophysiology
language:en
Short-container-title:Circ: Arrhythmia and Electrophysiology

Author:

Bos J. Martijn¹²,Crotti Lia³⁴⁵,Rohatgi Ram K.¹,Castelletti Silvia³,Dagradi Federica³,Schwartz Peter J.³,Ackerman Michael J.¹²⁶

Affiliation:

1. Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine (J.M.B., R.K.R., M.J.A.), Mayo Clinic, Rochester, MN.

2. Department of Molecular Pharmacology and Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory) (J.M.B., M.J.A.), Mayo Clinic, Rochester, MN.

3. Istituto Auxologico Italiano, IRCCS, Center for Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy (L.C., S.C., F.D., P.J.S.).

4. Department of Medicine and Surgery, University of Milano-Bicocca, Italy (L.C.).

5. Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy (L.C.).

6. Division of Heart Rhythm Services, Department of Cardiovascular Medicine (M.J.A.), Mayo Clinic, Rochester, MN.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Prevalence of the Congenital Long-QT Syndrome

2. Cardiac channelopathies: it's in the genes

3. Impact of Genetics on the Clinical Management of Channelopathies

4. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death

5. The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes, Transgenic Rabbits, and Patients;Circulation;2024-08-13

2. Multi-Faceted Approach to Ventricular Tachycardia: A Review of Management Strategies;Pharmacoepidemiology;2024-08-12

3. The proteostasis interactomes of trafficking-deficient variants of the voltage-gated potassium channel KV11.1 associated with long QT syndrome;Journal of Biological Chemistry;2024-07

4. Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation;European Heart Journal;2024-05-16

5. Congenital Long QT Syndrome in Children and Adolescents: A General Overview;Children;2024-05-11